Bioretec
0.07 EUR
+431.75 %
1,720 following
Corporate customer
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
+432.09 %
+167.02 %
+21.49 %
+19.11 %
-43.49 %
-66.18 %
-72.23 %
-
-74.12 %
Bioretec operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other materials for bone and soft tissue injuries. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic region.
Read moreMarket cap
101.08M EUR
Turnover
16.21K EUR
P/E (adj.) (26e)
-10.92
EV/EBIT (adj.) (26e)
-11
P/B (26e)
6.51
EV/S (26e)
20.4
Dividend yield-% (26e)
-
Coverage
Analyst
Latest research
Latest analysis report
Released: 2026-03-30
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
8/5
2026
General meeting '26
15/5
2026
Business review Q1'26
13/8
2026
Interim report Q2'26
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue
Bioretec Ltd's resolutions of the Extraordinary General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
